Claims for Patent: 5,688,761

Summary for Patent: 5,688,761

Title:	Convertible microemulsion formulations
Abstract:	There is provided a water-in-oil (w/o) micro emulsion which readily converts to an oil-in-water (o/w) emulsion by the addition of aqueous fluid to the w/o microemulsion, whereby an water-soluble biologically-active material in the aqueous phase is released for absorption by the body. The w/o microemulsion contains a preferred high purity short chain monoglyceride surfactant. The w/o microemulsion is particularly useful for storing proteins and the like for ling periods of time at room temperature and above until they are ready for use, at which time the addition of aqueous fluid converts the microemulsion to an o/w emulsion and release the protein.
Inventor(s):	Owen; Albert J. (West Chester, PA), Yiv; Seang H. (Wilmington, DE), Sarkahian; Ani B. (Bryn Mawr, PA)
Assignee:	LDS Technologies, Inc. (Boothwyn, PA)
Application Number:	08/406,862
Patent Claims:	1. A stable, water-in-oil microemulsion composition suitable for storage and administration of biologically active materials, comprising: (a) from about 5 to about 99 volume percent of an oil phase comprising at least one pharmaceutically acceptable oil; (b) up to about 60 volume percent of an aqueous phase comprising water; (c) a biologically active material having a water:oil partition coefficient greater than 10:1; (d) from about 1 to about 70 volume percent of a mixture of surfactants having a combined HLB value of from about 7 to about 14 comprising (i) a low HLB surfactant having an HLB below 8, said low HLB surfactant being at least 80 percent by weight of a C.sub.9 monoglyceride, C.sub.10 monoglyceride, C.sub.11 monoglyceride, C.sub.12 monoglyceride, or C.sub.13 monoglyceride, and (ii) at least one surfactant having an HLB value above about 8. 2. The water-in-oil microemulsion composition of claim 1 wherein the active material is a therapeutic and is a protein or a peptide. 3. The water-in-oil microemulsion composition of claim 2 wherein said water-in-oil microemUlsion composition contains a low HLB surfactant component that is at least 80 percent by weight of a surfactant selected from the group consisting of C.sub.9 monoglycerides, C.sub.10 monoglycerides, C.sub.11 monoglycerides, C.sub.12 monoglycerides, C.sub.13 monoglycerides, or mixtures thereof. 4. The water-in-oil microemulsion composition of claim 3 wherein said low HLB surfactant component is at least 90 percent by weight of said monoglycerides. 5. The water-in-oil microemulsion composition of claim 3 Wherein said low HLB surfactant component is at least 95 percent by weight of said monoglycerides. 6. The water-in-oil microemulsion composition of claim 3 wherein the oil phase comprises C.sub.9-45 triglycerides, C.sub.7-55 diesters of propylene glycol, and mixtures thereof. 7. The water-in-oil microemulsion composition of claim 3 wherein said low HLB surfactant component contains at least 80 percent by weight of a C.sub.11 monoglyceride. 8. The water-in-oil microemulsion composition of any of the claims 1, 2, 3, 4, 5, 6 or 7 wherein the composition is a solid at about 23.degree. C. 9. The water-in-oil microemulsion composition of any of the claims 1, 2, 3, 4, 5, 6 or 7 wherein the composition is a liquid at about 23.degree. C. 10. The water-in-oil microemulsion composition of any of the claims 2, 3, 4, 5, 6, or 7 wherein the biologically acitve material is selected from the group consisting of RGD peptides, calcitonins, insulins, fibrinogen antagonists, growth hormone releasing peptides, interleukins, erythropoietins, colony stimulating factors, hematoregulatory peptides, vasopressin, collagenase inhibitors, angiotensin inhibitors, mammalian growth hormones, heparins, clotting factors, tissue plasminogen activators, atrial natriuretic peptides, and tumor necrosis factor. 11. A stable, water-in-oil microemulsion composition suitable for storage and administration of biologically active materials, comprising: (a) from about 5 to about 99 volume percent of an oil phase comprising at least one pharmaceutically acceptable oil; (b) up to about 60 volume percent of an aqueous phase comprising water; (c) a biologically active material that is a therapeutic and is a protein or peptide and has a water:oil partition coefficient greater than 10:1; (d) from about 1 to about 70 volume percent of a mixture of surfactants having a combined HLB value of greater than about 7, comprising (i) a low HLB surfactant having an HLB below 8, said low HLB surfactant being at least 80 percent by weight of a C.sub.9 monoglyceride, C.sub.10 monoglyceride, C.sub.11 monoglyceride, C.sub.12 monoglyceride, or C.sub.13 monoglyceride, and (ii) at least one surfactant having an HLB value above about 8, and (e) a modifier, present in an amount sufficient to cause the water-in-oil microemulsion to convert to an oil-in-water microemulsion upon the addition of aqueous fluid. 12. The water-in-oil microemulsion composition of claim 11 wherein the modifier comprises sorbitol, polyethylene glycol, propylene glycol, mannitol, disaccharides, or mixtures thereof. 13. The water-in-oil microemulsion composition of claim 2 wherein said water-in-oil microemulsion composition contains a low HLB surfactant component that is at least 80 percent by weight of a surfactant selected from the group consisting of C.sub.9 monoglycerides, C.sub.10 monoglycerides, C.sub.11 monoglycerides, C.sub.12 monoglycerides, C.sub.13 monoglycerides, or mixtures thereof. 14. The water-in-oil microemulsion composition of any of the claims 11, 12, or 13, wherein the composition is a solid at about 23.degree. C. 15. The water-in-oil microemulsion composition of any of the claims 11, 12, or 13 wherein the composition is a liquid at about 23.degree. C. 16. A method of administering to animals a water-in-oil microemulsion composition, comprising: (a) providing a water-in-oil microemulsion comprising (1) from about 5 to about 99 volume percent of an oil phase comprising at least one pharmaceutically acceptable oil; (2) up to about 60 volume percent of an aqueous phase comprising water; (3) a biologically active material that is therpeutic and has a water:oil partition coefficient greater than 10:1; (4) from about 1 to about 70 volume percent of a mixture of surfactants having a combined HLB value of from about 7 to about 14 comprising (i) a low HLB surfactant having an HLB below 8, said low HLB surfactant being at least 80 percent by weight of a C.sub.9 monoglyceride, C.sub.10 monoglyceride, C.sub.11 monoglyceride, C.sub.12 monoglyceride, or C.sub.13 monoglyceride, and (ii) at least one surfactant having an HLB value above about 8; (b) administering an effective amount of the water-in-oil microemulsion to the body of an animal, wherein the administration is parenterally, enterally, or via any other mucous membrane; and (c) achieving a therapeutically elective increase in the blood system of said animal of said biologically-active material. 17. The method of claim 16 wherein the active agent is a protein or a peptide. 18. The method of claim 16 wherein the administration is orally. 19. The method of claim 18 wherein the administration is rectally. 20. The method of any of the claims 18 or 19 further comprising converting the water-in-oil microemulsion to an oil-in-water emulsion after the administration step by the addition of aeueous body fluid. 21. The water-in-oil microemulsion composition of claim 3 wherein said biologically active material comprises heparin or its derivatives. 22. The water-in-oil microemulsion composition of claim 13 wherein said biologically active material comprises heparin or its derivatives.

Details for Patent 5,688,761

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2039-02-26